
Ronald H. Coase Pfizer and Allergan called off their $150 billion merger this morning. What caused these two companies to call the whole thing off? The headline reason for not going through with the transaction was that the Treasury Department changed the rules on tax inversions. A tax inversion is a situation where a US-headquartered company, in this case Pfizer, merges with a … [Read more...]